Clinical Trials Browser

Phase 2 × Leukemia × tozasertib × Clear all

NCT00405054 2015-01-26

A Phase II Study of MK0457 in Patients With T315I Mutant CML and Ph+All (0457-008)

Phase 2 Terminated

Other hematologic neoplasm

Leukemia